Company Overview of Stemnion, Inc.
Stemnion, Inc., a regenerative medicine company, engages in the research and development of therapeutic products obtained from amnion-derived non-embryonic stem cells/placental stem cells. Its products target wound healing and tissue repair. The company’s product portfolio includes amnion-derived cellular cytokine solution, which is used to treat burns. Stemnion, Inc. was formerly known as Kytaron Technologies, Inc. The company was incorporated in 2001 and is based in Pittsburgh, Pennsylvania with an additional location in Clearwater, Florida.
100 Technology Drive
Pittsburgh, PA 15219
Founded in 2001
Key Executives for Stemnion, Inc.
Stemnion, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
December 31, 2015
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Stemnion, Inc., please visit www.stemnion.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.